Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults
Clinical trial NCT04783311 · COMPLETED
Trial details
- NCT number
- NCT04783311
- Sponsor
- EuBiologics Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2021-10-15
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.